|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.999
|
Human |
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.994
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.991
|
|
|
|
negative regulation of cell cycle arrest
|
GO:0071157 |
1 |
0.972
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.966
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.962
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.958
|
Human |
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.958
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.931
|
Mouse |
|
|
dna repair
|
GO:0006281 |
107 |
0.927
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.910
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
3 |
0.907
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.899
|
Mouse |
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.896
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.879
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.867
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.861
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.859
|
Human |
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.857
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
3 |
0.852
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.846
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.845
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.842
|
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.826
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.800
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
3 |
0.798
|
|
|
|
traversing start control point of mitotic cell cycle
|
GO:0007089 |
2 |
0.788
|
Mouse |
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.765
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.764
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.756
|
Mouse |
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.742
|
Mouse |
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.737
|
Mouse |
|
|
negative regulation of nik nf kappab signaling
|
GO:1901223 |
2 |
0.734
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.728
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.725
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.719
|
|
|
|
positive regulation of cell cycle g1 s phase transition
|
GO:1902808 |
9 |
0.716
|
Mouse |
|
|
negative regulation of dna damage response signal transduction by p53 class mediator
|
GO:0043518 |
5 |
0.709
|
|
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.701
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.696
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
3 |
0.695
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.692
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.689
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.679
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.677
|
|
|
|
response to antibiotic
|
GO:0046677 |
11 |
0.675
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.662
|
Human |
|
|
double strand break repair
|
GO:0006302 |
48 |
0.659
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.647
|
Mouse |
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.634
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.630
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.628
|
Mouse |
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.612
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.610
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.604
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.603
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.602
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.595
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.583
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.582
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.569
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.556
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.555
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.547
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.541
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.540
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.537
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.536
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.534
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.532
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.529
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.516
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.514
|
Mouse |
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.514
|
Mouse |
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.507
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.499
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.497
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.496
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.494
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.493
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.493
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.488
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.486
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.486
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.485
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.485
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.480
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.480
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.477
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.458
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
19 |
0.456
|
Human |
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.455
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.444
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.437
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.435
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.435
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.434
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.430
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
11 |
0.420
|
|
|
|
mitotic cell cycle arrest
|
GO:0071850 |
4 |
0.419
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.418
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.416
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.411
|
|
|
|
nucleotide excision repair
|
GO:0006289 |
13 |
0.410
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.406
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.406
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.404
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.402
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.402
|
Human |
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.396
|
Human Mouse |
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.392
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.391
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.387
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.385
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.384
|
Mouse |
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.384
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.382
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
12 |
0.382
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.377
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.377
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.375
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.360
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.356
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.355
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.353
|
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
3 |
0.351
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.350
|
|
|
|
cellular senescence
|
GO:0090398 |
11 |
0.350
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.347
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.336
|
|
|
|
telomere capping
|
GO:0016233 |
4 |
0.326
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.325
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.325
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.324
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.323
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.320
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.313
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.309
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.309
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.304
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.304
|
Mouse |
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.300
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.297
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.293
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.291
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.291
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.289
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.288
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.284
|
Human |
|
|
mitochondrion degradation
|
GO:0000422 |
3 |
0.278
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.265
|
Mouse |
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.262
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.259
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.257
|
|
|
|
positive regulation of g1 s transition of mitotic cell cycle
|
GO:1900087 |
9 |
0.255
|
Mouse |
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.254
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase activity
|
GO:0043553 |
1 |
0.253
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.252
|
Mouse |
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.251
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.251
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.251
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.250
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.249
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.237
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.237
|
|
|
|
mitochondrial dna repair
|
GO:0043504 |
3 |
0.235
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.235
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.232
|
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
27 |
0.232
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
21 |
0.231
|
Human |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.230
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.230
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.230
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.229
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.226
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.224
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.223
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.221
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.221
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.220
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.215
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.215
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.214
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.214
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.210
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.208
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.207
|
Mouse |
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.206
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.206
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.204
|
|
|
|
positive regulation of striated muscle cell apoptotic process
|
GO:0010663 |
3 |
0.203
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.201
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.201
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.201
|
Human Mouse |
|
|
epidermal growth factor receptor signaling pathway via positive regulation of nf kappab transcription factor activity
|
GO:0038167 |
1 |
0.199
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.198
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.198
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.197
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.192
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.190
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.189
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.188
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.184
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.184
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.183
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.181
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.180
|
Mouse |
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.180
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.179
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.179
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.179
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.178
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
10 |
0.178
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.175
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.175
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.174
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.174
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.169
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.163
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.160
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
28 |
0.159
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.158
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.157
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
25 |
0.157
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.157
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.155
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.155
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.155
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.153
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.152
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.152
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.152
|
|
|
|
epidermal growth factor receptor signaling pathway via i kappab kinase nf kappab cascade
|
GO:0038168 |
1 |
0.151
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.151
|
Mouse |
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.148
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.147
|
Mouse |
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.147
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.146
|
Human |
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.145
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.140
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.138
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.137
|
|
|
|
macroautophagy
|
GO:0016236 |
21 |
0.136
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.136
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.135
|
Human |
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.134
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.134
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.132
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.132
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.128
|
Mouse |
|
|
cellular response to oxygen levels
|
GO:0071453 |
20 |
0.127
|
Human |
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.127
|
|
|
|
negative regulation of fibroblast proliferation
|
GO:0048147 |
14 |
0.127
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.126
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.126
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.126
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.126
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.125
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.123
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.123
|
|
|
|
reciprocal dna recombination
|
GO:0035825 |
16 |
0.122
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.122
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.122
|
|
|
|
positive regulation of cardiac muscle cell apoptotic process
|
GO:0010666 |
3 |
0.122
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.121
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
2 |
0.121
|
|
|
|
myeloid cell apoptotic process
|
GO:0033028 |
22 |
0.121
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
18 |
0.121
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.120
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.120
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.120
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.120
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
26 |
0.119
|
|
|
|
telomere maintenance in response to dna damage
|
GO:0043247 |
4 |
0.119
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.119
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.118
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.118
|
|
|
|
positive regulation of muscle cell apoptotic process
|
GO:0010661 |
6 |
0.116
|
|
|
|
regulation of autophagy
|
GO:0010506 |
30 |
0.116
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.116
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.116
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.115
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.114
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.113
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.113
|
|
|
|
negative regulation of jun kinase activity
|
GO:0043508 |
9 |
0.112
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.110
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.110
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.108
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.108
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.106
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.105
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.102
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.102
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.102
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.101
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.100
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.100
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.098
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.098
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.097
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.097
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.097
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.097
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.096
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.095
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.094
|
|
|
|
negative regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032435 |
15 |
0.094
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.094
|
|
|
|
protection from non homologous end joining at telomere
|
GO:0031848 |
4 |
0.093
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.093
|
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
16 |
0.093
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.092
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
19 |
0.092
|
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
19 |
0.092
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.092
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.091
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.091
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.091
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.090
|
|
|
|
negative regulation of cell division
|
GO:0051782 |
24 |
0.090
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.089
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.088
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.088
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.088
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.088
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.088
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.088
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.087
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.087
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.087
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.086
|
|
|
|
cellular response to drug
|
GO:0035690 |
15 |
0.086
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.086
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.086
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.085
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.085
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.085
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.085
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.085
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.085
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.084
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.084
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.084
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.083
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.083
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.083
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
10 |
0.082
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.082
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.082
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.081
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
27 |
0.080
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.080
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.080
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.080
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.079
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.079
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.079
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.078
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.078
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.077
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.077
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.076
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.076
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.076
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.076
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.075
|
|
|
|
base excision repair
|
GO:0006284 |
9 |
0.075
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.074
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.074
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.074
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.073
|
|
|
|
negative regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0045736 |
9 |
0.073
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.073
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.072
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.072
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.072
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.072
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.071
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.071
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.071
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.070
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.070
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.070
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.070
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.070
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.069
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.069
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.069
|
|
|
|
positive regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032436 |
23 |
0.069
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.069
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.068
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.068
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.067
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.067
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.067
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.067
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.066
|
|
|
|
positive regulation of cell cycle arrest
|
GO:0071158 |
10 |
0.066
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.065
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.065
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.064
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.064
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.064
|
|
|
|
negative regulation of lipid kinase activity
|
GO:0090219 |
1 |
0.063
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.063
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
18 |
0.063
|
Human |
|
|
pallium development
|
GO:0021543 |
120 |
0.063
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.063
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
17 |
0.062
|
Human |
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.062
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.062
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.062
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.061
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.061
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.061
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.061
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.060
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.060
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.060
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.060
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.060
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.059
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.059
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.059
|
Mouse |
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.059
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.059
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.059
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.058
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.058
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.058
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.058
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.058
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
38 |
0.057
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.057
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
21 |
0.057
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.057
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.057
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.057
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.056
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.056
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.056
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.056
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.056
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.056
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.056
|
|
|
|
rna dependent dna replication
|
GO:0006278 |
3 |
0.056
|
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.055
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.055
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.055
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.055
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.055
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.054
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.054
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.054
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.054
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.054
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.054
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.054
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.054
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.054
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.054
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.054
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.053
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.053
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.053
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.053
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.053
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.053
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.053
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.052
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.052
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.052
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.052
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.051
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.051
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.051
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.051
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.051
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.051
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.050
|
|